Carisma Therapeutics, Inc. Stock
Stocks
CARM
US14216R1014
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
11:31:00 2026-06-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-92.31% | -99.77% |
| Market Cap | 1.8M 1.55M 1.46M 1.33M 2.49M 170M 2.5M 17.21M 6.68M 87.16M 6.76M 6.61M 281M | P/E 2023 |
-1.13x | P/E 2024 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -14.55M -12.52M -11.78M -10.76M -20.14M -1.37B -20.19M -139M -54.03M -705M -54.65M -53.46M -2.27B | EV / Sales 2023 |
2,933,403x | EV / Sales 2024 | 57,658x |
| Free-Float |
76.96% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -92.31% | ||
| Current month | -92.31% | ||
| 1 month | -96.00% | ||
| 6 months | -99.76% | ||
| Current year | -99.77% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.44 |
| 3 years | 0 | | 5.22 |
| 5 years | 0 | | 9.77 |
| 10 years | 0 | | 9.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 65 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
BRD | Director/Board Member | 65 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/25 | Exercice | Founder | 170,946 | 0.4095% | ||
| 10/1/25 | Sell | Founder | 484,347 | 1.1601% | ||
| 1/28/25 | Free | Chief Executive Officer | 500,000 | 1.1976% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -92.31% | -99.98% | -100.00% | 29.29K | |
| -0.38% | -2.64% | +42.69% | +99.03% | 67.98B | |
| -2.48% | -0.48% | +34.39% | +81.84% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | |
| -1.42% | -4.28% | +31.24% | +13.27% | 25.74B | |
| -1.11% | +0.90% | +23.12% | -18.50% | 20.09B | |
| +1.15% | -14.24% | +219.82% | +381.14% | 17.16B | |
| +0.20% | -4.68% | -6.41% | +560.92% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | |
| Average | -0.37% | +0.94% | +28.00% | +154.75% | 27.91B | |
| Weighted average by Cap. | -0.76% | +0.59% | +37.04% | +141.21% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 14.92 12.84 12.08 11.03 20.64 1.41K 20.7 142.73 55.39 722.7 56.02 54.8 2.33K | 19.63 16.89 15.89 14.52 27.16 1.85K 27.24 187.82 72.88 951.01 73.72 72.11 3.06K |
| Net income | -86.88M -74.76M -70.34M -64.25M -120M -8.2B -121M -831M -323M -4.21B -326M -319M -13.56B | -60.48M -52.04M -48.96M -44.73M -83.67M -5.71B -83.9M -579M -225M -2.93B -227M -222M -9.44B |
| Net Debt | -74.48M -64.09M -60.3M -55.09M -103M -7.03B -103M -713M -277M -3.61B -280M -274M -11.62B | -16.35M -14.07M -13.24M -12.09M -22.62M -1.54B -22.69M -156M -60.71M -792M -61.41M -60.07M -2.55B |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$0.000700 | -22.22% | 992 |
| 26-09-03 | US$0.000900 | +28.57% | 16,567 |
| 26-09-02 | US$0.000700 | -30.00% | 6,207 |
| 26-09-01 | US$0.001000 | -23.08% | 7,746 |
| 26-08-31 | US$0.001300 | -.--% | 24,378 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARM Stock
Select your edition
All financial news and data tailored to specific country editions
